Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
1.09M
-
Shares change
-
-669K
-
Total reported value, excl. options
-
$1.97M
-
Value change
-
-$437K
-
Put/Call ratio
-
0.73
-
Number of buys
-
3
-
Number of sells
-
-5
-
Price
-
$1.80
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q1 2024
15 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q1 2024.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.09M shares
of 129M outstanding shares and own 0.84% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (765K shares), Point72 Asia (Singapore) Pte. Ltd. (141K shares), CITADEL ADVISORS LLC (126K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (46K shares), Bank of New York Mellon Corp (12.6K shares), HARBOUR INVESTMENTS, INC. (1.71K shares), NBC SECURITIES, INC. (150 shares), JPMORGAN CHASE & CO (94 shares), GSA CAPITAL PARTNERS LLP (0 shares), and Castleview Partners, LLC (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.